|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 21 | 2022 | Response to the Comment on ‘‘Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by He et al. | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 42 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 43 | 2022 | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-Jean | Journal Contribution | A1 |
| 44 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 45 | 2021 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 46 | 2021 | Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, Stefan | Journal Contribution | A1 |
| 47 | 2021 | A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis | Brufsky, A.; Kim, S. B.; Zvirbule, Z.; Eniu, A.; MEBIS, Jeroen; Sohn, J. H.; Wongchenko, M.; Chohan, S.; Amin, R.; Yan, Y.; McNally, V; Miles, D.; Loi, S. | Journal Contribution | A1 |
| 48 | 2020 | Preliminary results of a multicentric, placebo-controlled clinical trial | ROBIJNS, Jolien; LODEWIJCKX, Joy; Puts , Sofie; Claes, Stefan; Van Bever, Leen; Busse, Lore; Colson , Dora; Kaminski, Iris; Broux, Victoria; MAES, Annelies; BULENS, Paul; Noe, Leen; Brosens, Marc; Govers, Mieke; Timmermans, An; MEBIS, Jeroen | Journal Contribution | M |
| 49 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 50 | 2020 | A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies | ROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 51 | 2020 | Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results | Catala, Gaetan; MEBIS, Jeroen; Jerusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van Den Broeck, Anke; Duhoux, Francois P; Machiels, Jean-Pascal | Journal Contribution | A1 |
| 52 | 2019 | Low-level laser therapy for the prevention of acute radiodermatitis in breast cancer patients: a randomized, placebo-controlled clinical trial (TRANSDERMIS trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Censabella, Sandrine; Claes, Stefan; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | M |
| 53 | 2019 | Photobiomodulation therapy for acute radiodermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | A1 |
| 54 | 2019 | Systematic screening and assessment of psychosocial well-being and care needs of people with cancer | SCHOUTEN, Bojoura; Avau, Bert; Bekkering, Geertruida; Vankrunkelsven, Patrick; MEBIS, Jeroen; HELLINGS, Johan; Van Hecke, Ann | Journal Contribution | A1 |
| 55 | 2019 | Letter to the Editor concerning the article “Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer” | ROBIJNS, Jolien; Censabella, S; Claes, S; Pannekoeke, L; Bussé, L; Colson, D; Kaminski, I; Broux, V; LODEWIJCKX, Joy; Puts, S; BULENS, Paul; MAES, Annelies; Noé, L; Brosens, M; Timmermans, A; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 56 | 2018 | Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial). | ROBIJNS, Jolien; Censabella, Sandrine; Claes, Stefan; Pannekoeke, Luc; Bussé, Lore; Colson, Dora; Kaminski, Iris; BULENS, Paul; MAES, Annelies; Noé, Leen; Brosens, Marc; Timmermans, An; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 57 | 2018 | Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Bussé, L.; Colson, D.; Kaminski, I.; LODEWIJCKX, Joy; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | A1 |
| 58 | 2018 | Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review | COSEMANS, Charlotte; OBEN, Bénedith; ARIJS, Ingrid; Daniels, Annick; DECLERCQ, Jeroen; VANHEES, Kimberly; FROYEN, Guy; MAES, Brigitte; MEBIS, Jeroen; RUMMENS, Jean-Luc | Journal Contribution | A1 |
| 59 | 2018 | Photobiomodulation prevents acute radiodermatitis: final results of a RCT in bre ast cancer patients | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Busse, L.; Kaminksi, I.; Colson, D.; MAES, Annelies; BULENS, Paul; Noe, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
| 60 | 2018 | Photobiomodulation therapy prevents severe acute radiodermatitis: a randomized, placebo-controlled trial in breast cancer patients with clinical and objective outcome measures | ROBIJNS, Jolien; Censabella, S.; Claes, S.; Pannekoeke, L.; Bussé, L.; Colson, D.; Kaminksi, I.; BULENS, Paul; MAES, Annelies; Noé, L.; Brosens, M.; Timmermans, A.; LAMBRICHTS, Ivo; SOMERS, Veerle; MEBIS, Jeroen | Journal Contribution | M |
Loading...
5
0
5
0
false